By Business/Source
Currency:USD
2025/Q3
Stock NameRevenueRatio
Life Sciences Services25.73M58.16%
Life Sciences Products18.82M42.55%
Elimination of intersegment revenue-316K-0.71%
By Country/Region
Currency:USD
2024/FY
Stock NameRevenueRatio
Americas126.37M55.33%
Europe, Middle East and Africa (EMEA)59.6M26.09%
Asia Pacific (APAC)42.42M18.57%